Work

651O Phase II trial of pembrolizumab (P) in combination with sEphB4-HSA (B4) in previously treated metastatic urothelial carcinoma (mUC)

Year: 2021

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.047

Authors: S. Sadeghi, D.I. Quinn, T. Dorff, S.K. Pal, S. Groshen, D. Tsao-Wei, P.N. Lara, R. Parikh, M.E. Devitt, M. Parikh, A. Jackovich, N.J. Vogelzang, E.F. Burgess, R. Dreicer, I. Siddiqi, I. Gill, P. Gill

Institutions: USC Norris Comprehensive Cancer Center, City Of Hope National Medical Center, City of Hope, University of Southern California, UC Davis Comprehensive Cancer Center, University of California, Davis, University of Kansas, University of Virginia Cancer Center, Rutgers, The State University of New Jersey, Comprehensive Cancer Centers of Nevada, Levine Cancer Institute

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3203973997

FWCI: 1.063

Cites:

Cited by: 5

Related to: 10